Please ensure Javascript is enabled for purposes of website accessibility

Clorox Won’t Catch Up With Demand for Disinfecting Wipes Until Summer

By Rich Duprey – May 8, 2020 at 12:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

And the maker of Lysol has no idea when it will be able to meet demand.

Clorox (CLX -1.23%) says demand for its branded disinfecting wipes is running so high that despite operating around the clock, reducing choice, and using third-party manufacturers to add additional capacity, it still won't be able to catch up until the summer.

Cleaning up from wiping down

The Wall Street Journal reports that despite Clorox increasing production of disinfecting products by 40% during the coronavirus pandemic, demand for those items has surged five-fold. CFO Kevin Jacobsen told the Journal: "We're shipping canisters of wipes every day to our customers, and within 30-45 minutes they're gone from shelves. Demand has outstripped what anybody could have imagined."

Woman looking at bottle of bleach

Image source: Getty Images.

Clorox isn't alone. Reckitt Benckiser (RBGL.Y -1.56%), the maker of Lysol disinfecting spray, has also been unable to match the pace of demand, but it doesn't know when it will be able to catch up. In a public statement, it apologized for not being able to deliver as much product as consumers wanted, but said it was "experiencing unprecedented and accelerated demand."

Clorox anticipates that even after the worst of the COVID-19 pandemic passes, consumers will be looking to maintain a cleaner environment and will continue wiping down surfaces more frequently.

It will be adding a new production line for disinfecting products at an Atlanta factory that has excess space and has converted other production lines to focus on it primary wipes, instead of other products.

Clorox reported first-quarter results earlier this month showing an 18% increase in organic sales volumes, and that was only for a period that captured a few weeks of the pandemic. Analysts are expecting it to see significant more growth in the second quarter.

 

Rich Duprey has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clorox Stock Quote
Clorox
CLX
$130.07 (-1.23%) $-1.62
Reckitt Benckiser Group plc Stock Quote
Reckitt Benckiser Group plc
RBGL.Y
$13.24 (-1.56%) $0.21

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
339%
 
S&P 500 Returns
109%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.